(2S)-16-(methylamino)-8,13,15-trioxo-2-[2-[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxyethyl-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]amino]-N-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]hexadecanamide

C42H75N3O21 — CID 159225751

IUPAC(2S)-16-(methylamino)-8,13,15-trioxo-2-[2-[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxyethyl-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]amino]-N-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]hexadecanamide
SMILESCNCC(=O)CC(=O)CCCCC(=O)CCCCC[C@@H](C(=O)NCCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)N(CCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)CCO[C@H]1C[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O
InChIInChI=1S/C42H75N3O21/c1-43-19-26(51)18-25(50)9-6-5-8-24(49)7-3-2-4-10-27(40(61)44-11-14-63-41-38(59)36(57)33(54)29(21-47)65-41)45(12-15-62-28-17-23(20-46)31(52)35(56)32(28)53)13-16-64-42-39(60)37(58)34(55)30(22-48)66-42/h23,27-39,41-43,46-48,52-60H,2-22H2,1H3,(H,44,61)/t23-,27+,28+,29-,30-,31-,32-,33-,34-,35+,36+,37+,38+,39+,41+,42+/m1/s1
InChIKeyWTVTVCKXCYSWLK-XTHNSLKQSA-N
MW958.06 g/mol
LogP-6.29
Rot. Bonds32

About (2S)-16-(methylamino)-8,13,15-trioxo-2-[2-[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxyethyl-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]amino]-N-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]hexadecanamide

(2S)-16-(methylamino)-8,13,15-trioxo-2-[2-[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxyethyl-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]amino]-N-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]hexadecanamide (PubChem CID 159225751) has the molecular formula C42H75N3O21 and a molecular weight of 958.06 g/mol. Its IUPAC name is (2S)-16-(methylamino)-8,13,15-trioxo-2-[2-[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxyethyl-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]amino]-N-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]hexadecanamide.

Molecular Properties

Compound Name(2S)-16-(methylamino)-8,13,15-trioxo-2-[2-[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxyethyl-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]amino]-N-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]hexadecanamide
PubChem CID159225751
Molecular FormulaC42H75N3O21
Molecular Weight958.06 g/mol
Exact Mass957.49
IUPAC Name(2S)-16-(methylamino)-8,13,15-trioxo-2-[2-[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxyethyl-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]amino]-N-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]hexadecanamide
SMILESCNCC(=O)CC(=O)CCCCC(=O)CCCCC[C@@H](C(=O)NCCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)N(CCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)CCO[C@H]1C[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O
InChIInChI=1S/C42H75N3O21/c1-43-19-26(51)18-25(50)9-6-5-8-24(49)7-3-2-4-10-27(40(61)44-11-14-63-41-38(59)36(57)33(54)29(21-47)65-41)45(12-15-62-28-17-23(20-46)31(52)35(56)32(28)53)13-16-64-42-39(60)37(58)34(55)30(22-48)66-42/h23,27-39,41-43,46-48,52-60H,2-22H2,1H3,(H,44,61)/t23-,27+,28+,29-,30-,31-,32-,33-,34-,35+,36+,37+,38+,39+,41+,42+/m1/s1
InChIKeyWTVTVCKXCYSWLK-XTHNSLKQSA-N
XLogP-6.29
TPSA384.49 Ų
H-Bond Donors14
H-Bond Acceptors23
Rotatable Bonds32
Heavy Atoms66
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500958.06
LogP ≤ 5-6.29
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Analyze (2S)-16-(methylamino)-8,13,15-trioxo-2-[2-[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxyethyl-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]amino]-N-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]hexadecanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-16-(methylamino)-8,13,15-trioxo-2-[2-[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxyethyl-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]amino]-N-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]hexadecanamide?
The IUPAC name of (2S)-16-(methylamino)-8,13,15-trioxo-2-[2-[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxyethyl-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]amino]-N-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]hexadecanamide (CID 159225751) is (2S)-16-(methylamino)-8,13,15-trioxo-2-[2-[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxyethyl-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]amino]-N-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]hexadecanamide.
What is the SMILES notation for (2S)-16-(methylamino)-8,13,15-trioxo-2-[2-[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxyethyl-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]amino]-N-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]hexadecanamide?
The canonical SMILES for (2S)-16-(methylamino)-8,13,15-trioxo-2-[2-[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxyethyl-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]amino]-N-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]hexadecanamide is CNCC(=O)CC(=O)CCCCC(=O)CCCCC[C@@H](C(=O)NCCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)N(CCO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O)CCO[C@H]1C[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O.
What is the InChIKey of (2S)-16-(methylamino)-8,13,15-trioxo-2-[2-[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxyethyl-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]amino]-N-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]hexadecanamide?
The InChIKey is WTVTVCKXCYSWLK-XTHNSLKQSA-N. The full InChI is InChI=1S/C42H75N3O21/c1-43-19-26(51)18-25(50)9-6-5-8-24(49)7-3-2-4-10-27(40(61)44-11-14-63-41-38(59)36(57)33(54)29(21-47)65-41)45(12-15-62-28-17-23(20-46)31(52)35(56)32(28)53)13-16-64-42-39(60)37(58)34(55)30(22-48)66-42/h23,27-39,41-43,46-48,52-60H,2-22H2,1H3,(H,44,61)/t23-,27+,28+,29-,30-,31-,32-,33-,34-,35+,36+,37+,38+,39+,41+,42+/m1/s1.
What are the key properties of (2S)-16-(methylamino)-8,13,15-trioxo-2-[2-[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxyethyl-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]amino]-N-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]hexadecanamide?
(2S)-16-(methylamino)-8,13,15-trioxo-2-[2-[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxyethyl-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]amino]-N-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]hexadecanamide has a molecular weight of 958.06 g/mol, XLogP of -6.29, 32 rotatable bonds, 14 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-16-(methylamino)-8,13,15-trioxo-2-[2-[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxyethyl-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]amino]-N-[2-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]hexadecanamide is sourced from PubChem (CID 159225751), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).